Hypersomnia’s and Neurologic Sleep Disorders

These practice parameters pertain to the treatment of hypersomnia’s of central origin. It serves as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnia of central origin. Specific disorders addressed by these parameters are narcolepsy (with or without cataplexy, due to medical condition), the idiopathic hypersomnia, recurrent hypersomnia and hyperxsomnia due to medical condition. Central hypersomnias are diseases manifested in excessive daytime sleepiness (EDS) not caused by disturbed nocturnal sleep or misaligned circadian rhythms. The Central hypersomnias includes narcolepsy with or without cataplexy, idiopathic hypersomnia. recurrent hypersomnia, with and without long sleep , behaviorally induced insufficient sleep disorder, Narcolepsy and hypersomnia due to medical conditions, and finally hypersomnia induced by substance intake. Epworth Sleepiness Scale is a subjective tool mostly used for Excessive daytime sleepiness assessment, Whereas the Multiple Sleep Latency Test serves as an objective diagnostic method for narcolepsy and idiopathic hypersomnias. As for symptomatic therapy of EDS, the central nervous system stimulants modafinil and methylphenidate seem to work well in most cases and in narcolepsy and Parkinson’s disease; sodium oxybate also has notable therapeutic value. In 1966, William Dement proposed that patients with excessive daytime sleepiness, but without cataplexy, sleep paralysis, or sleep-onset rapid eye movement (REM), should not be considered narcoleptic. In 1972, Roth described a type of hypersomnia with sleep drunkenness that consists of difficulty coming to complete wakefulness, confusion, disorientation, poor motor coordination, and slowness, accompanied by deep and prolonged sleep. The abrupt sleep attacks seen in classic narcolepsy are not present in this disorder.

  • Primary hypersomnias : origin and causes
  • Primary hypersomnia mimics and genetic roots
  • Secondary hypersomnias as underlying symptoms of other disorders

Related Conference of Hypersomnia’s and Neurologic Sleep Disorders

February 03-04, 2025

37th World Conference on Neurology

London, UK
February 17-18, 2025

5th International Conference on Child Neurology

Aix-en-Provence, France
February 20-21, 2025

6th International Conference on Neurologists

Amsterdam, Netherlands
February 24-25, 2025

4th International Conference onAlzheimer and Dementia

Madrid, Spain
February 27-28, 2025

7th World Depression Congress

Paris, France
March 10-11, 2025

8th World Conference on Neuroscience

Paris, France
March 13-14, 2025

7th World Conference on Neuroscience

Prague, Czech Republic
March 24-25, 2025

38th European Neurology Congress 2025

London, UK
April 24-25, 2025

6th World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
April 29-30, 2025

11th International Conference on Epilepsy & Treatment

Barcelona, Spain
May 12-13, 2025

39th European Neurology Congress

London, UK
July 17-18, 2025

31st Annual Summit on Neuroscience & Neurological Disorders

Amsterdam, Netherlands
July 23-24, 2025

15th Global Alzheimers Summit

Paris, France
July 28-29, 2025

35th World Congress on Neurology and Neuroscience

Paris, France
August 25-26, 2025

20th Annual Congress on Neuroscience

Aix-en-Provence, France
September 25-26, 2025

12th Annual congress on Stroke and Neurological Disorders

Zurich, Switzerland
October 20-21, 2025

7th World Brain Congress

Osaka, Japan
October 29-30, 2025

5th Annual Dementia Congress

Amsterdam, Netherlands
November 13-14, 2025

38th International Conference on Neuroscience and Neurochemistry

Aix-en-Provence, France

Hypersomnia’s and Neurologic Sleep Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in